Published in J Clin Pharm Ther on April 01, 2007
Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing. Clin Pharmacol Ther (2011) 5.44
Primary care physicians' knowledge of and experience with pharmacogenetic testing. Clin Genet (2012) 2.07
Survey of genetic counselors and clinical geneticists' use and attitudes toward pharmacogenetic testing. Clin Genet (2012) 1.70
Personalized medicine and genomics: challenges and opportunities in assessing effectiveness, cost-effectiveness, and future research priorities. Med Decis Making (2010) 1.45
Personal genome testing in medical education: student experiences with genotyping in the classroom. Genome Med (2013) 1.44
Personalized medicine: is it a pharmacogenetic mirage? Br J Clin Pharmacol (2012) 1.44
Insurance coverage policies for personalized medicine. J Pers Med (2012) 1.19
Clinically available pharmacogenomics tests. Clin Pharmacol Ther (2009) 1.13
Public perspectives about pharmacogenetic testing and managing ancillary findings. Genet Test Mol Biomarkers (2011) 1.11
Professional perspectives about pharmacogenetic testing and managing ancillary findings. Genet Test Mol Biomarkers (2011) 1.01
Scientific challenges and implementation barriers to translation of pharmacogenomics in clinical practice. ISRN Pharmacol (2013) 0.98
Implementation of TPMT testing. Br J Clin Pharmacol (2014) 0.96
Improving pharmacovigilance in Europe: TPMT genotyping and phenotyping in the UK and Spain. Eur J Hum Genet (2009) 0.95
Pharmacogenetic testing: Current Evidence of Clinical Utility. Ther Adv Drug Saf (2013) 0.87
Understanding chemotherapy treatment pathways of advanced colorectal cancer patients to inform an economic evaluation in the United Kingdom. Br J Cancer (2010) 0.84
Genetic analysis of thiopurine methyltransferase polymorphism in the Jordanian population. Eur J Clin Pharmacol (2010) 0.82
Translating translation into patient benefit for atopic eczema. Br J Dermatol (2016) 0.75
Clinician adoption of genetic testing for drug metabolizing enzymes: is patient safety the low-hanging fruit of personalized medicine? AMIA Annu Symp Proc (2009) 0.75
Pharmacogenomics: personalizing pediatric heart transplantation. Circulation (2015) 0.75
Ethical issues in pediatric pharmacogenomics. J Pediatr Pharmacol Ther (2013) 0.75
Thiopurine S-methyltransferase polymorphisms in acute lymphoblastic leukemia, inflammatory bowel disease and autoimmune disorders: influence on treatment response. Pharmgenomics Pers Med (2017) 0.75
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell (1998) 17.76
The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell (1996) 17.13
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell (1997) 15.96
CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature (1996) 11.37
Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature (1999) 8.23
floricaula: a homeotic gene required for flower development in antirrhinum majus. Cell (1990) 6.52
Circulating adhesion molecules in disease. Immunol Today (1993) 6.22
Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci U S A (1999) 5.78
CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature (1997) 5.45
CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J Exp Med (1997) 5.18
The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell (2000) 4.53
RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci U S A (2000) 3.95
Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin Invest (1996) 3.74
Neural activity relating to generation and representation of galvanic skin conductance responses: a functional magnetic resonance imaging study. J Neurosci (2000) 3.49
Activation-independent binding of human memory T cells to adhesion molecule ELAM-1. Nature (1991) 3.45
Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J Exp Med (1996) 3.33
Lymphocyte interactions with endothelial cells. Immunol Today (1992) 3.31
Histochemical Studies on Tissue Enzymes: III. A Study of the Distribution of Acid Phosphatases with Special Reference to the Nervous System. Am J Pathol (1943) 3.31
Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue. Am J Pathol (1997) 3.24
IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1. J Immunol (1992) 2.89
The alpha-chemokine, stromal cell-derived factor-1alpha, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways. J Biol Chem (1998) 2.88
Clinical failures associated with rpoB mutations in phenotypically occult multidrug-resistant Mycobacterium tuberculosis. Int J Tuberc Lung Dis (2012) 2.78
Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules. J Exp Med (1991) 2.76
Multidisciplinary team management is associated with improved outcomes after surgery for esophageal cancer. Dis Esophagus (2006) 2.60
Response inhibition and impulsivity: an fMRI study. Neuropsychologia (2003) 2.45
CD31 expressed on distinctive T cell subsets is a preferential amplifier of beta 1 integrin-mediated adhesion. J Exp Med (1992) 2.38
Rapid construction of large synthetic genes: total chemical synthesis of two different versions of the bovine prochymosin gene. Gene (1987) 2.36
The influence of vector behavior on malaria transmission. Am J Trop Med Hyg (1972) 2.34
Four molecular pathways of T cell adhesion to endothelial cells: roles of LFA-1, VCAM-1, and ELAM-1 and changes in pathway hierarchy under different activation conditions. J Cell Biol (1991) 2.27
Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Arthritis Rheum (2007) 2.18
ATAR, a novel tumor necrosis factor receptor family member, signals through TRAF2 and TRAF5. J Biol Chem (1997) 2.15
Identification and functional characterization of two distinct epitopes on the human T cell surface protein Tp50. J Immunol (1983) 2.13
Adhesion through the LFA-1 (CD11a/CD18)-ICAM-1 (CD54) and the VLA-4 (CD49d)-VCAM-1 (CD106) pathways prevents apoptosis of germinal center B cells. J Immunol (1994) 2.11
Resolution of peanut allergy: case-control study. BMJ (1998) 2.11
TACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulation. J Exp Med (2000) 2.10
Prognostic significance of 18-FDG PET/CT and EUS-defined tumour characteristics in patients with oesophageal cancer. Clin Radiol (2012) 2.08
Clinical and economic choices in anaesthesia for day surgery: a prospective randomised controlled trial. Anaesthesia (2003) 2.08
Utilization of C-C chemokine receptor 5 by the envelope glycoproteins of a pathogenic simian immunodeficiency virus, SIVmac239. J Virol (1997) 2.04
T cells bind to cytokine-activated endothelial cells via a novel, inducible sialoglycoprotein and endothelial leukocyte adhesion molecule-1. J Immunol (1990) 2.00
Measurement of in vivo proliferation in human colorectal mucosa using bromodeoxyuridine. Gut (1992) 1.93
Patients with stable long-standing rheumatoid arthritis continue to deteriorate despite intensified treatment with traditional disease modifying anti-rheumatic drugs--results of the British Rheumatoid Outcome Study Group randomized controlled clinical trial. Rheumatology (Oxford) (2005) 1.84
Prospective study of 424 cases of Staphylococcus aureus bacteraemia: determination of factors affecting incidence and mortality. Intern Med J (2001) 1.83
Propofol and halothane versus sevoflurane in paediatric day-case surgery: induction and recovery characteristics. Br J Anaesth (2003) 1.78
Attention, memory, and motor skills as childhood predictors of schizophrenia-related psychoses: the New York High-Risk Project. Am J Psychiatry (2000) 1.77
Hepatobiliary complications of total parenteral nutrition. Gastroenterology (1993) 1.76
Rapid resolution of chronic colitis in the cotton-top tamarin with an antibody to a gut-homing integrin alpha 4 beta 7. Gastroenterology (1996) 1.74
Interleukin 2 induces gamma-interferon production: participation of macrophages and NK-like cells. J Immunol (1983) 1.72
Anti-Mullerian hormone-tailored stimulation protocols improve outcomes whilst reducing adverse effects and costs of IVF. Hum Reprod (2011) 1.72
Cloning and characterization of the aldA gene of Aspergillus nidulans. Gene (1987) 1.70
Accumulation of coronary artery disease risk factors over three years: data from an international inception cohort. Arthritis Rheum (2008) 1.65
The independence of intrinsic radiosensitivity as a prognostic factor for patient response to radiotherapy of carcinoma of the cervix. Br J Cancer (1997) 1.63
Increased chromosomal radiosensitivity in breast cancer patients: a comparison of two assays. Int J Radiat Biol (1999) 1.61
Attention to pain localization and unpleasantness discriminates the functions of the medial and lateral pain systems. Eur J Neurosci (2005) 1.60
Review of biomarkers in colorectal cancer. Colorectal Dis (2012) 1.59
Utilization of psychotherapy research by practicing psychotherapists. Am Psychol (1986) 1.55
Undesirable cytokeratin immunoreactivity of native nonepithelial cells in sentinel lymph nodes from patients with breast carcinoma. Arch Pathol Lab Med (2000) 1.52
Stage-for-stage comparison of definitive chemoradiotherapy, surgery alone and neoadjuvant chemotherapy for oesophageal carcinoma. Br J Surg (2009) 1.52
The effect of increasing the treatment time beyond three weeks on the control of T2 and T3 laryngeal cancer using radiotherapy. Radiother Oncol (1992) 1.51
Lack of behavioural effects after acute tyrosine depletion in healthy volunteers. J Psychopharmacol (2005) 1.47
Differential diagnosis of dementia: a prospective evaluation of the DAT Inventory. J Am Geriatr Soc (1994) 1.47
Arthritic pain is processed in brain areas concerned with emotions and fear. Arthritis Rheum (2007) 1.47
Genetic predisposition in breast cancer. Lancet (1994) 1.47
Nitric oxide binding to nitrophorin 4 induces complete distal pocket burial. Nat Struct Biol (2000) 1.46
Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case-control study. Br J Nutr (2003) 1.46
Discrete steps in binding and signaling of interleukin-8 with its receptor. J Biol Chem (1996) 1.42
Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast. J Clin Endocrinol Metab (1999) 1.42
Intrinsic radiosensitivity and prediction of patient response to radiotherapy for carcinoma of the cervix. Br J Cancer (1993) 1.42
Postoperative recurrence of Crohn's disease: impact of endoscopic monitoring and treatment step-up. Colorectal Dis (2013) 1.42
Cost-effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion: a systematic review and economic model. Health Technol Assess (2006) 1.41
Nutritional status and assessment of patients on home parenteral nutrition: anthropometry, bioelectrical impedance, or clinical judgment? Nutrition (1999) 1.39
Relationship between in vitro chromosomal radiosensitivity of peripheral blood lymphocytes and the expression of normal tissue damage following radiotherapy for breast cancer. Radiother Oncol (2000) 1.39
Emergency nurses' moral evaluation of patients. J Emerg Nurs (1994) 1.37
Fetal heart rate and acid-base status in the assessment of fetal hypoxia. Am J Obstet Gynecol (1967) 1.35
Expression of VCAM-1 and E-selectin in an in vivo model of endothelial activation. Am J Pathol (1993) 1.35
Identification of viable embryos in IVF by non-invasive measurement of amino acid turnover. Hum Reprod (2004) 1.34
The neural basis of maternal responsiveness to infants: an fMRI study. Neuroreport (2004) 1.34
Evidence for T cell nature and heterogeneity within natural killer (NK) and antibody-dependent cellular cytotoxicity (ADCC) effectors: a comparison with cytolytic T lymphocytes (CTL). J Immunol (1981) 1.33
"Are all psychotherapies equivalent?". Am Psychol (1986) 1.32
The role of nonrandomized trials in the evaluation of oncology drugs. Clin Pharmacol Ther (2015) 1.32
Crosslinking of the T cell-specific accessory molecules CD7 and CD28 modulates T cell adhesion. J Exp Med (1992) 1.31
X-linked retinoschisis: clinical phenotype and RS1 genotype in 86 UK patients. J Med Genet (2005) 1.30
Cranial hemihypertrophy and neurodevelopmental prognosis. J Med Genet (1990) 1.29
Prediction error for free monetary reward in the human prefrontal cortex. Neuroimage (2004) 1.28
The influence of surface atmospheric conditions on the range and area reached by animal vocalizations. J Exp Biol (1997) 1.28
A chemical inhibitor of PPM1D that selectively kills cells overexpressing PPM1D. Oncogene (2007) 1.27
A survey of adolescent experiences of human papillomavirus vaccination in the Manchester study. Br J Cancer (2009) 1.27
The temporal and spatial changes in cell proliferation within the irradiated crypts of the murine small intestine. Int J Radiat Biol (1990) 1.26
Ophthalmologic aspects of amyloidosis. Am J Ophthalmol (1970) 1.25
Nosocomial influenza B virus infection in the elderly. Ann Intern Med (1982) 1.25
Bone geometry and density in the skeleton of pre-pubertal gymnasts and school children. Bone (2005) 1.25
The aetiology and pathology of pterygium. Trans Ophthalmol Soc Aust (1966) 1.24
The mouse Mid1 gene: implications for the pathogenesis of Opitz syndrome and the evolution of the mammalian pseudoautosomal region. Hum Mol Genet (1998) 1.24
The crypt cycle in mouse small intestinal epithelium. J Cell Sci (1994) 1.24
Ribozyme minigene-mediated RAD51 down-regulation increases radiosensitivity of human prostate cancer cells. Nucleic Acids Res (2001) 1.24
Fetal acid-base status. 1. Relationship between maternal and fetal pCO2. Am J Obstet Gynecol (1967) 1.23
Radiosensitivity testing of primary cervical carcinoma: evaluation of intra- and inter-tumour heterogeneity. Radiother Oncol (1990) 1.23